SYSTEMIC AND CUTANEOUS PLASMACYTOSIS WITH MULTIPLE SKIN-LESIONS AND POLYCLONAL HYPERGAMMAGLOBULINEMIA - SIGNIFICANT SERUM INTERLEUKIN-6 LEVELS

被引:52
作者
KODAMA, A
TANI, M
HORI, K
TOZUKA, T
MATSUI, T
ITO, M
NAKAO, S
FUJITA, T
KOBAYASHI, H
机构
[1] KOBE UNIV,SCH MED,DEPT DERMATOL,5 KUSUNOKI CHO 7 CHOME,CHUO KU,KOBE 650,JAPAN
[2] KOBE NATL HOSP,DEPT DERMATOL,SUMA KU,KOBE 654,JAPAN
[3] KOBAYASHI DERMATOL CLIN,SUMA KU,KOBE 654,JAPAN
[4] KOBE UNIV,SCH MED,DEPT INTERNAL MED,KOBE 650,JAPAN
关键词
D O I
10.1111/j.1365-2133.1992.tb14827.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report two patients who developed benign plasmacytosis with multiple skin lesions. The cases were characterized by hyperplasia of mature plasma cells, and polyclonal hypergammaglobulinaemia. One patient had hyperplasia of mature plasma cells not only in the skin, but also extensively in lymph nodes and the retroperitoneal areas around the ureters. The other had plasma cell hyperplasia limited to the skin. Extensive investigations failed to reveal any clinical or laboratory evidence suggesting the presence of any underlying disease accompanying the hypergammaglobulinaemia and/or plasma cell proliferation, such as chronic infectious disease, collagen disease or other chronic inflammatory disorder. Clinically and histologically, the first patient showed features compatible with a diagnosis of systemic plasmacytosis and the second with a diagnosis of cutaneous plasmacytosis. Significant serum interleukin-6 (IL-6) levels were detected in both patients, suggesting that IL-6 may be involved in the pathogenesis of these conditions.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 27 条
[1]   RECOMBINANT HUMAN B-CELL STIMULATORY FACTOR-II (BSF-2/IFN-BETA2) REGULATES BETA-FIBRINOGEN AND ALBUMIN MESSENGER-RNA LEVELS IN FAO-9 CELLS [J].
ANDUS, T ;
GEIGER, T ;
HIRANO, T ;
NORTHOFF, H ;
GANTER, U ;
BAUER, J ;
KISHIMOTO, T ;
HEINRICH, PC .
FEBS LETTERS, 1987, 221 (01) :18-22
[2]  
CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO
[3]  
2-4
[4]   A SYSTEMIC LYMPHOPROLIFERATIVE DISORDER WITH MORPHOLOGIC FEATURES OF CASTLEMANS DISEASE - PATHOLOGICAL FINDINGS IN 15 PATIENTS [J].
FRIZZERA, G ;
BANKS, PM ;
MASSARELLI, G ;
ROSAI, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1983, 7 (03) :211-231
[5]  
GABA AR, 1978, AM J CLIN PATHOL, V69, P86
[7]   COMPLEMENTARY-DNA FOR A NOVEL HUMAN INTERLEUKIN (BSF-2) THAT INDUCES LYMPHOCYTES-B TO PRODUCE IMMUNOGLOBULIN [J].
HIRANO, T ;
YASUKAWA, K ;
HARADA, H ;
TAGA, T ;
WATANABE, Y ;
MATSUDA, T ;
KASHIWAMURA, S ;
NAKAJIMA, K ;
KOYAMA, K ;
IWAMATSU, A ;
TSUNASAWA, S ;
SAKIYAMA, F ;
MATSUI, H ;
TAKAHARA, Y ;
TANIGUCHI, T ;
KISHIMOTO, T .
NATURE, 1986, 324 (6092) :73-76
[8]   EXCESSIVE PRODUCTION OF INTERLEUKIN-6/B CELL STIMULATORY FACTOR-II IN RHEUMATOID-ARTHRITIS [J].
HIRANO, T ;
MATSUDA, T ;
TURNER, M ;
MIYASAKA, N ;
BUCHAN, G ;
TANG, B ;
SATO, K ;
SHIMIZU, M ;
MAINI, R ;
FELDMAN, M ;
KISHIMOTO, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (11) :1797-1801
[9]  
HOUSSIAU FA, 1988, CLIN EXP IMMUNOL, V71, P320
[10]   INTERLEUKIN-6 IN SYNOVIAL-FLUID AND SERUM OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND OTHER INFLAMMATORY ARTHRITIDES [J].
HOUSSIAU, FA ;
DEVOGELAER, JP ;
VANDAMME, J ;
DEDEUXCHAISNES, CN ;
VANSNICK, J .
ARTHRITIS AND RHEUMATISM, 1988, 31 (06) :784-788